Biodata:
Myung-Ju Ahn is Professor of Hemato-Oncology at the Department of Medicine, Sungkyunkwan University School of Medicine, Seoul. She is a member of numerous research associations and societies, including the IASLC, AACR, and ASCO and is currently Chief of the Executive Committee and Chairperson of Lung Cancer Disease Committee of the KCSG and a director of Korean Association for Lung Cancer Association (KALC). She was the president of the Korean Soceity of Medical Oncology (KSMO) and was chairperson of the multidisciplinary Immuno-oncology Study Group (2017–2018). She is a board member for the Korea Cancer Society (KCA) and KSMO, and is on the editorial board of Journal of Thoracic Oncology.          
Prof Ahn received her medical and doctoral degrees from Hanyang University College of Medicine, Seoul and completed her residency training at Hanyang University Hospital. She has held numerous research fellowships, including a postdoctoral research fellowship at the Memorial Sloan-Kettering Cancer Center, New York, and has authored over 300 cancer research publications. Her research interests include the development of predictive and prognostic markers for personalised lung cancer therapy. She has recently focused on early clinical trials for the development of drug discovery and reposition of targeted drugs and the development of a NSCLC genome atlas. Her accolades for her dedication to cancer research include Best Researcher Award, Korean Medical Women Association (2003); Best Researcher Award from Korean Society of Medical Oncology (2015); Boryoung Scientific Award from Korean Cancer Research Foundation (2018), Wunsch Medical Award from Korean Academy of Medical Science (2020), Excellent researcher Award from Minister of Health and Welfare (2021) and Highly Cited Researcher, Clavirate analytics (2019,2020,2021,2022)